Latest filing published 29 Jun 2018 for MusclePharm Corp, €644k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Amerop Holdings, Inc.: trading record in brief
Amerop Holdings, Inc. discloses dealings in MusclePharm Corp to SEC (Form 4). We count 18 filings; the first trade dates from 4 April 2017 and the latest from 22 June 2018.
Both buying and selling appear: 17 purchases worth €353k, against 1 sale worth €644k. Netting one side against the other leaves €292k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2018, the count stands at no purchases and 1 sale.
In size, the median ticket on the buying side is €1,520. Across 14 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The record was last updated on 29 June 2018 with an open-market sale (€644k) in MusclePharm Corp. The last insider purchase was made public on 15 May 2017, 3,465 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Amerop Holdings, Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 747,942 shares@ US$1.00100.0% of flowCommon StockSEC:0001209191-18-040072:0
- 75,000 shares@ US$2.0013.9% of flowCommon StockSEC:0001104659-17-032676:0Canonical exit: 9 Aug 2017 (T+90)
- 2,200 shares@ US$2.170.5% of flowCommon StockSEC:0001104659-17-022920:0Canonical exit: 9 Jul 2017 (T+90)
- 300 shares@ US$2.170.1% of flowCommon StockSEC:0001104659-17-022920:1Canonical exit: 9 Jul 2017 (T+90)
- 500 shares@ US$2.170.1% of flowCommon StockSEC:0001104659-17-022920:2Canonical exit: 9 Jul 2017 (T+90)
- 2,300 shares@ US$2.170.5% of flowCommon StockSEC:0001104659-17-022920:3Canonical exit: 9 Jul 2017 (T+90)
- 14,000 shares@ US$2.152.9% of flowCommon StockSEC:0001104659-17-022920:4Canonical exit: 9 Jul 2017 (T+90)
- 100 shares@ US$2.110.0% of flowCommon StockSEC:0001104659-17-021949:0Canonical exit: 3 Jul 2017 (T+90)
- 34,800 shares@ US$2.127.0% of flowCommon StockSEC:0001104659-17-021949:2Canonical exit: 3 Jul 2017 (T+90)
- 762 shares@ US$2.120.2% of flowCommon StockSEC:0001104659-17-021949:3Canonical exit: 3 Jul 2017 (T+90)
- 762 shares@ US$2.130.2% of flowCommon StockSEC:0001104659-17-021949:6Canonical exit: 3 Jul 2017 (T+90)
- 2,500 shares@ US$2.140.5% of flowCommon StockSEC:0001104659-17-021949:7Canonical exit: 3 Jul 2017 (T+90)
- 5,000 shares@ US$2.151.0% of flowCommon StockSEC:0001104659-17-021949:9Canonical exit: 3 Jul 2017 (T+90)
- 41,900 shares@ US$2.158.5% of flowCommon StockSEC:0001104659-17-021949:10Canonical exit: 4 Jul 2017 (T+90)
- 152 shares@ US$2.150.0% of flowCommon StockSEC:0001104659-17-021949:8Canonical exit: 3 Jul 2017 (T+90)
15 of 15 declarations